Gene arrays and temporal patterns of drug response: Corticosteroid effects on rat liver

Functional and Integrative Genomics

Volumn 3, Issue 4, 2003, Pages 171-179

  Almon, Richard R ^a   DuBois, Debra C ^a   Pearson, Keri E ^b   Stephan, Dietrich A ^b   Jusko, William J ^a  

^a UNIVERSITY AT BUFFALO   (United States)

^b CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

Author keywords

Cluster analysis; Corticosteroids; Expression profiling; Glucocorticoids

Indexed keywords

CORTICOSTEROID; GLUCOCORTICOID RECEPTOR; METHYLPREDNISOLONE; GLUCOCORTICOID; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CLUSTER ANALYSIS; COMPUTER PROGRAM; CONTROLLED STUDY; DNA MICROARRAY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG EFFICACY; DRUG RESPONSE; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE IDENTIFICATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIVER; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHARMACOGENOMICS; PRIORITY JOURNAL; RAT; RAT STRAIN; RNA ISOLATION; STATISTICAL ANALYSIS; ADRENALECTOMY; ANIMAL; BLOOD; DRUG EFFECT; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC TRANSCRIPTION; METABOLISM; TIME; WISTAR RAT;

ADRENAL CORTEX HORMONES; ADRENALECTOMY; ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CLUSTER ANALYSIS; GENE EXPRESSION; GENE EXPRESSION PROFILING; GLUCOCORTICOIDS; LIVER; MALE; METHYLPREDNISOLONE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RATS; RATS, WISTAR; RECEPTORS, GLUCOCORTICOID; RNA, MESSENGER; TIME FACTORS; TRANSCRIPTION, GENETIC;

EID: 0141441683     PISSN: 1438793X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10142-003-0090-x     Document Type: Article

References (24)

1. Adcock I (2000) Molecular mechanisms of glucocorticosteroid actions. Pulm Pharmacol Ther 13:115-126 10.1006/pupt.2000.0243
2. Almon R, DuBois DC, Brandenburg E, Shi W, Zhang S, Straubinger RM, Jusko WJ (2002) Pharmacodynamics and pharmacogenomics of diverse receptor-mediated effects of methylprednisolone in rats using microarray analysis. J Pharmacokin Pharmacodyn 29:103-129 10.1023/A:1019762323576
3. Baxter J (2000) Advances in glucocorticoid therapy. Adv Intern Med 45:317-349 1:STN:280:DC%2BD3c7gtV2ksw%3D%3D
4. Berdanier CD (1989) Role of glucocorticoids in the regulation of lipogenesis. FASEB J 3:2179-2183 1:CAS:528:DyaL1MXltV2isrc%3D
5. Bialas MC, Routledge PA (1998) Adverse effects of corticosteroids. Adverse Drug React Toxicol Rev 17:227-235 1:CAS:528:DyaK1MXisVSlt7Y%3D
6. Burton G, Guan Y, Nagarajan R, McGehee R (2002) Microarray analysis of gene expression during early adipocyte differentiation. Gene 293:21-31 10.1016/S0378-1119(02)00726-6
7. DePrimo S, Diehn M, Nelson J, Reiter R, Matese J, Fero M, Tibshirani R, Brown P, Brooks J (2002) Transcriptional programs activated by exposure of human prostate cancer cells to androgen. Genome Biol 3:32 10.1186/ gb-2002-3-7-research0032
8. Ebling WF, Szefler SJ, Jusko WJ (1985) Methylprednisolone disposition in rabbits: Analysis, prodrug conversion, reversible metabolism and comparison with man. Drug Metab Dispos 13:296-304 1:CAS:528:DyaL2MXktlanu74%3D
9. Evans R (1988) The steroid and thyroid hormone superfamily. Science 240:889-895 1:CAS:528:DyaL1cXktVSqsr4%3D
10. Frauman AG (1996) An overview of the adverse reactions to adrenal corticosteroids. Adverse Drug React Toxicol Rev 15:203-206 1:STN:280:ByiB28jpt1w%3D
11. Gustafsson J, Carlsteat-Duke J, Poellinger L, Okret S, Wikstrom AC, Bronnegard M, Gillner M, Dong Y, Fuxe K, Cintra A (1987) Biochemistry, molecular biology, and physiology of the glucocorticoid receptor. Endocr Rev 8:185-234 1:STN:280:BiiB2srntlI%3D
12. McMahon M, Gerich J, Rizza R (1988) Effects of glucocorticoids on carbohydrate metabolism. Diabetes Metabol Rev 4:17-30 1:CAS:528:DyaK3cXlvVCktr4%3D
13. Moran J, Li Y, Hill A, Mounts W, Miller C (2002) Gene expression changes during mouse skeletal myoblast differentiation revealed by transcriptional profiling. Physiol Genomics 10:103-111 1:CAS:528:DC%2BD38XntFyjtrs%3D
14. Nadadur S, Kodavanti U (2002) Altered gene expression profiles of rat lung in response to an emission particulate and its metal constituents. J Toxicol Environ Health Part A 65:1333-1350 10.1080/00984100290071559
15. Pannen BH, Robotham JL (1995) The acute-phase response. New Horizons 3:183-197 1:STN:280:BymD1c3islA%3D
16. Parmentier-Batteur S, Jin K, Xie L, Mao X, Greenberg D (2002) DNA microarray analysis of cannabinoid signaling in mouse brain in vivo. Mol Pharmacol 62:828-835 10.1124/mol.62.4.828
17. Prough RA, Linder MW, Pinaire JA, Xiao GH, Falkner KC (1996) Hormonal regulation of hepatic enzymes involved in foreign compound metabolism. FASEB J 10:1369-1377 1:CAS:528:DyaK28XmsVSgu74%3D
18. Ramakrishnan R, DuBois DC, Almon RR, Pyszczynski NA, Jusko WJ (2002) Pharmacodynamics and pharmacogenomics of methylprednisolone during seven-day infusion in rats. J Pharmacol Exper Ther 300:245-256 10.1124/ jpet.300.1.245
19. Schimmer BP, Parker KL (1996) Adrenocorticotrophic hormones; adrenocortical steroids and their synthetic analogs; inhibitors of the synthesis and actions of adrenocortical hormones. In: Hardman JG, Limbird LE, Molinoff PB, R. Ruddon RW, Goodman Gilman A (eds) Goodman & Gilman's The pharmacological basis of therapeutics. McGraw Hill, New York, pp 1459-1486
20. Shalev A, Pise-Masison C, Radonovich M, Hoffmann S, Hirshberg B, Brady J, Harlan D (2002) Oligonucleotide microarray analysis of intact human pancreatic islets: Identification of glucose-responsive genes and a highly regulated TGFbeta signaling pathway. Endocrinology 143:3695-3698 10.1210/en.2002-220564
21. Sun Y-N, DuBois DC, Almon RR, Pyszczynski NA, Jusko WJ (1998a) Dose-dependence and repeated-dose studies for receptor/gene-mediated pharmacodynamics of methylprednisolone on glucocorticoid receptor down-regulation and tyrosine aminotransferase induction in rat liver. J Pharmacokin Biopharm 26:619-648 10.1023/A:1020746822634
22. Sun Y-N, DuBois, D.C., Almon, R.R. Jusko, W.J (1998b) Fourth-generation model for corticosteroid pharmacodynamics: A model for methylprednisolone effects on receptor/gene-mediated glucocorticoid receptor down-regulation and tyrosine aminotransferase induction in rat liver. J Pharmacokin Biopharm 26:289-317 10.1023/A:1023233409550
23. Sun Y-N, McKay LI, DuBois DC, Jusko WJ, Almon RR (1999) Pharmacokinetic/ pharmacodynamic models for corticosteroid receptor down-regulation and glutamine synthetase induction in rat skeletal muscle by a receptor/ gene-mediated mechanism. J Pharmacol Exp Ther 288:720-728 1:CAS:528:DyaK1MXpvFOmsA%3D%3D
24. Takiguchi, M., Mori, M. (1985) Transcriptional regulation of genes for ornithine cycle enzymes. Biochem J 312: 649-659